Kiyoshi F Fukutani Selected Research

Ligands

1/2019

Chronic hepatitis B virus infection drives changes in systemic immune activation profile in patients coinfected with Plasmodium vivax malaria.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kiyoshi F Fukutani Research Topics

Disease

10	Tuberculosis (Tuberculoses) 01/2021 - 01/2017
7	Infections 11/2021 - 01/2012
7	Inflammation (Inflammations) 01/2021 - 01/2017
5	Coinfection 01/2021 - 01/2017
4	Immune Reconstitution Inflammatory Syndrome 01/2021 - 01/2019
4	Cutaneous Leishmaniasis 12/2020 - 01/2012
3	Pulmonary Tuberculosis 01/2021 - 01/2019
2	Diabetes Complications 12/2023 - 01/2017
2	Pneumonia (Pneumonitis) 01/2021 - 12/2019
2	Extrapulmonary Tuberculosis 11/2019 - 11/2019
1	Insulin Resistance 12/2023
1	Chromosomal Instability (Chromosome Stability) 12/2023
1	Parasitemia 11/2021
1	Opportunistic Infections (Opportunistic Infection) 01/2021
1	COVID-19 01/2021
1	Confusion (Bewilderment) 01/2021
1	Lymphopenia (Lymphocytopenia) 01/2021
1	Sepsis (Septicemia) 01/2021
1	Measles 09/2020
1	Chickenpox 09/2020
1	Rubella (German Measles) 09/2020
1	Mumps 09/2020
1	Hepatitis B 09/2020
1	Human Influenza (Influenza) 09/2020
1	Prediabetic State (Prediabetes) 01/2020
1	Diffuse Cutaneous Leishmaniasis 01/2020
1	Dysbiosis 01/2020
1	Anemia 01/2019
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 01/2019
1	Starvation 01/2018
1	Noncommunicable Diseases 01/2017
1	Disease Susceptibility (Diathesis) 11/2016
1	Hypersensitivity (Allergy) 01/2011

Drug/Important Bio-Agent (IBA)

9	Biomarkers (Surrogate Marker)IBA 11/2020 - 01/2017
5	VaccinesIBA 01/2021 - 01/2012
4	CytokinesIBA 01/2021 - 01/2019
3	Rifampin (Rifampicin)FDA LinkGeneric 01/2021 - 01/2019
3	InterleukinsIBA 01/2021 - 01/2019
2	Interleukin-4 (Interleukin 4)IBA 11/2021 - 01/2012
2	Interleukin-17 (Interleukin 17)IBA 01/2021 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 03/2020 - 01/2011
2	Inflammation MediatorsIBA 01/2020 - 11/2019
2	LipidsIBA 01/2020 - 11/2019
2	C-Reactive ProteinIBA 11/2019 - 01/2019
2	EnzymesIBA 01/2019 - 01/2017
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 12/2023
1	Urea (Carbamide)FDA LinkGeneric 01/2021
1	Rotavirus VaccinesIBA 09/2020
1	Interferon Type IIBA 03/2020
1	InterferonsIBA 03/2020
1	MicroRNAs (MicroRNA)IBA 01/2020
1	Amino Acids FDA Link 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	PolyaminesIBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 11/2019
1	lipopolysaccharide-binding proteinIBA 11/2019
1	Matrix Metalloproteinase 7 (Matrilysin)IBA 11/2019
1	ChemokinesIBA 01/2019
1	LigandsIBA 01/2019
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2019
1	Hemoglobins (Hemoglobin)IBA 01/2019
1	lipoarabinomannan (LAM)IBA 01/2019
1	Uric Acid (Urate)IBA 01/2019
1	CreatinineIBA 01/2019
1	BilirubinIBA 01/2019
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2019
1	WortmanninIBA 01/2018
1	1- ((2- ((2- chloropyridin- 4yl)amino)- 4'- (cyclopropylmethyl)- (4,5'- bipyrimidin)- 2'- yl)amino)- 2- methylpropan- 2- olIBA 01/2018
1	RNA (Ribonucleic Acid)IBA 01/2018
1	Chloroquine (Aralen)FDA LinkGeneric 01/2018
1	Sirolimus (Rapamycin)FDA Link 01/2018
1	AntioxidantsIBA 01/2017
1	Heme Oxygenase-1IBA 01/2017
1	Histones (Histone)IBA 01/2012

Therapy/Procedure

7	Therapeutics 01/2021 - 01/2017
2	Art Therapy 01/2021 - 01/2019